Cargando…
Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine
Combinations of doxorubicin and streptozocin and 5-FU and dacarbazine were given alternately to 20 patients with metastatic medullary thyroid carcinoma. Three partial responses and 10 long-term stabilizations were observed. No unexpected toxicity occurred. © 2000 Cancer Research Campaign
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2000
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363532/ https://www.ncbi.nlm.nih.gov/pubmed/10952773 http://dx.doi.org/10.1054/bjoc.2000.1314 |
| _version_ | 1782153728191627264 |
|---|---|
| author | Nocera, M Baudin, E Pellegriti, G Cailleux, A F Mechelany-Corone, C Schlumberger, M |
| author_facet | Nocera, M Baudin, E Pellegriti, G Cailleux, A F Mechelany-Corone, C Schlumberger, M |
| author_sort | Nocera, M |
| collection | PubMed |
| description | Combinations of doxorubicin and streptozocin and 5-FU and dacarbazine were given alternately to 20 patients with metastatic medullary thyroid carcinoma. Three partial responses and 10 long-term stabilizations were observed. No unexpected toxicity occurred. © 2000 Cancer Research Campaign |
| format | Text |
| id | pubmed-2363532 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2000 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-23635322009-09-10 Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine Nocera, M Baudin, E Pellegriti, G Cailleux, A F Mechelany-Corone, C Schlumberger, M Br J Cancer Regular Article Combinations of doxorubicin and streptozocin and 5-FU and dacarbazine were given alternately to 20 patients with metastatic medullary thyroid carcinoma. Three partial responses and 10 long-term stabilizations were observed. No unexpected toxicity occurred. © 2000 Cancer Research Campaign Nature Publishing Group 2000-09 2000-08-17 /pmc/articles/PMC2363532/ /pubmed/10952773 http://dx.doi.org/10.1054/bjoc.2000.1314 Text en Copyright © 2000 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Regular Article Nocera, M Baudin, E Pellegriti, G Cailleux, A F Mechelany-Corone, C Schlumberger, M Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine |
| title | Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine |
| title_full | Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine |
| title_fullStr | Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine |
| title_full_unstemmed | Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine |
| title_short | Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine |
| title_sort | treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 fu-dacarbazine |
| topic | Regular Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363532/ https://www.ncbi.nlm.nih.gov/pubmed/10952773 http://dx.doi.org/10.1054/bjoc.2000.1314 |
| work_keys_str_mv | AT noceram treatmentofadvancedmedullarythyroidcancerwithanalternatingcombinationofdoxorubicinstreptozocinand5fudacarbazine AT baudine treatmentofadvancedmedullarythyroidcancerwithanalternatingcombinationofdoxorubicinstreptozocinand5fudacarbazine AT pellegritig treatmentofadvancedmedullarythyroidcancerwithanalternatingcombinationofdoxorubicinstreptozocinand5fudacarbazine AT cailleuxaf treatmentofadvancedmedullarythyroidcancerwithanalternatingcombinationofdoxorubicinstreptozocinand5fudacarbazine AT mechelanycoronec treatmentofadvancedmedullarythyroidcancerwithanalternatingcombinationofdoxorubicinstreptozocinand5fudacarbazine AT schlumbergerm treatmentofadvancedmedullarythyroidcancerwithanalternatingcombinationofdoxorubicinstreptozocinand5fudacarbazine AT treatmentofadvancedmedullarythyroidcancerwithanalternatingcombinationofdoxorubicinstreptozocinand5fudacarbazine |